Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review (CROSBI ID 241762)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Vuk, Antonia ; Baretić, Maja ; Matovinović Osvatić, Martina ; Filipčić, Igor ; Jovanović, Nikolina ; Rojnić Kuzman, Martina Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review // Journal of clinical psychopharmacology, 37 (2017), 5; 584-589. doi: 10.1097/JCP.0000000000000772

Podaci o odgovornosti

Vuk, Antonia ; Baretić, Maja ; Matovinović Osvatić, Martina ; Filipčić, Igor ; Jovanović, Nikolina ; Rojnić Kuzman, Martina

engleski

Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review

The second-generation antipsychotics (SGAs) are associated with metabolic disturbances. Diabetic ketoacidosis (DKA) is a rare, but potentially fatal sign of acute glucose metabolism dysregulation, which may be associated with the use of SGAs. This study aims to review published reports of patients with schizophrenia and antipsychotic drug- associated DKA, focusing on the effective management of both conditions. Using a predefined search strategy, we searched PubMed and EMBASE from their inception to July 2016. The search terms were related to "diabetic ketoacidosis" and "antipsychotic medication." Case reports, case series, and reviews of case series written in English language were included in the review. Sixty-five reports were analyzed. In most patients who developed antipsychotic-associated DKA, 1 or more suspected antipsychotic medications were discontinued. In 5 cases, a rechallenge test was trialed, and in only 1 case, it resulted in the elevation of blood glucose. The majority was subsequently treated with a different SGA in combination with insulin/oral hypoglycemic agents ; although approximately a third of patients had a complete resolution of symptoms or could control diabetes with diet only at the point of discharge. Patients taking antipsychotic medications should be regularly screened for insulin resistance and educated about potential complications of antipsychotic medications. This will allow clinicians to individualize treatment decisions and reduce iatrogenic contribution to morbidity and mortality. To achieve best treatment outcomes, antipsychotic- induced DKA should be treated jointly by psychiatry and endocrinology teams.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

second-generation antipsychotics ; diabetic ketoacidosis ; therapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

37 (5)

2017.

584-589

objavljeno

0271-0749

10.1097/JCP.0000000000000772

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost